Celemics, Inc. Logo

Celemics, Inc.

Develops NGS target enrichment solutions for research and clinical applications.

331920 | KO

Overview

Corporate Details

ISIN(s):
KR7331920009
LEI:
Country:
South Korea
Address:
서울특별시 금천구 가산디지털1로 131, A동 19층 및 20층 2004호 외, 금천구

Description

Celemics, Inc. is a biotechnology company that develops and provides Next-Generation Sequencing (NGS) solutions for research and clinical applications. The company specializes in hybridization-based target enrichment technology, offering a comprehensive portfolio of products and services. This includes ready-to-use and customized NGS panels, whole exome sequencing kits, library preparation kits, modular accessories, and bioinformatics analysis services. Celemics' solutions support a wide range of fields, including oncology (somatic cancer, liquid biopsy), inherited diseases, pathogen analysis, pharmacogenomics, and immune repertoire profiling. A key focus is the development of end-to-end customized target enrichment panels, providing support from assay design and optimization to complete bioinformatics analysis. The company's proprietary technologies in probe design and molecular barcoding enable efficient analysis of diverse and challenging sample types.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-11-14 00:00
분기보고서 (2024.09)
Korean HTML 1.1 MB
2024-09-26 00:00
단일판매ㆍ공급계약체결(자율공시)
Korean HTML 8.7 KB
2024-09-26 00:00
[기재정정]단일판매ㆍ공급계약체결(자율공시)
Korean HTML 11.9 KB
2024-08-16 00:00
조회공시요구(현저한시황변동)에대한답변(중요정보없음)
Korean HTML 4.6 KB
2024-08-14 00:00
반기보고서 (2024.06)
Korean HTML 1.1 MB
2024-08-14 00:00
조회공시요구(현저한시황변동)
Korean HTML 3.5 KB
2024-07-04 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean HTML 12.8 KB
2024-06-28 00:00
기타시장안내 (업종변경 안내)
Korean HTML 4.7 KB
2024-05-17 00:00
[기재정정]분기보고서 (2024.03)
Korean HTML 1.1 MB
2024-05-16 00:00
분기보고서 (2024.03)
Korean HTML 876.5 KB
2024-03-29 00:00
정기주주총회결과
Korean HTML 22.5 KB
2024-03-21 00:00
사업보고서 (2023.12)
Korean HTML 407.5 KB
2024-03-20 00:00
감사보고서제출
Korean HTML 25.1 KB
2024-03-06 00:00
[기재정정]주주총회소집공고
Korean HTML 717.3 KB
2024-03-04 00:00
주주총회소집결의
Korean HTML 9.3 KB

Automate Your Workflow. Get a real-time feed of all Celemics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Celemics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Celemics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.